~~<i id='B68A52E2B8'><strike id='B68A52E2B8'><tt id='B68A52E2B8'><pre id='B68A52E2B8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

entertainment

author：Wikipedia 2025-10-02 20:49:18 - browse：2366

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： CEOs share strategies for surviving biotech slump

entertainment

hotspot

focus

Wikipedia

leisure time

1:27FTXfounderSamBankman-FriedisledawayhandcuffedbyofficersoftheRoyalBahamasPoliceForceinNassau,Baha

WSS

Lessons Learned: This is why you network to find that industry job you want

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Eli Lilly expects to double planned employment in Boston center

Former Georgia lieutenant governor says he received grand jury subpoena

FDA struggles to regulate food additives, sometimes for decades

Hospitals use virtual reality to design more inclusive rooms for kids

Wikipedia

entertainment

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Astronauts get first look at the spacecraft that will fly them around the moon

ChatGPT in medicine: STAT answers readers' burning questions

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharmacists can make shortage drugs, but at what cost?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Studies point to risks of excluding people with obesity from drug trials

The high cost of giving birth even with insurance

FTX founder Sam Bankman

hotspot

HHS leader on health, climate change and biopharma emissions

Pharmacists can make shortage drugs, but at what cost?

Sage's campaign to raise awareness of postpartum depression hits a nerve

STAT Summit: Michael J. Fox on progress in Parkinson's research

Beam Therapeutics to lay off 20% of its staff, re

Pharmacists can make shortage drugs, but at what cost?

focus

Wikipedia

Wikipedia

leisure time